Feasibility and Preliminary Efficacy of an Internet-Delivered Intervention for Insomnia in Individuals with Mild Cognitive Impairment

Manuscript Number: 

21-0657R2

Author(s): 
Laura Barnes, Eric M. Davis, Michelle Eckstein, Carol A. Manning, Meghan K. Mattos, Mark Quigg, Lee M. Ritterband, Ann Sollinger

Disclosures

Laura Barnes

  • Nothing to Disclose

Eric M. Davis

  • Nothing to Disclose

Michelle Eckstein

  • Nothing to Disclose

Carol A. Manning

  • Nothing to Disclose

Meghan K. Mattos

  • Nothing to Disclose

Mark Quigg

  • Nothing to Disclose

Lee M. Ritterband

  • Consulting Fees:
    Dr. Ritterband reports having a financial and/or business interest in BeHealth Solutions and Pear Therapeutics, two companies that develop and disseminate digital therapeutics, including by licensing the therapeutic developed, based in part, on early versions of the software utilized in research reported in the enclosed paper. Dr. Ritterband is also a consultant to Mahana Therapeutics, a separate digital therapeutic company not affiliated with this research. These companies had no role in preparing this manuscript. The terms of these arrangements have been reviewed and approved by the University of Virginia in accordance with its policies.
    Equity:
    Dr. Ritterband is a co-founder and has stock in BeHealth Solutions. He is on the Board of Directors.
    Patents/Royalties
    Dr. Ritterband receives royalties through UVA and BeHealth Solutions via Pear Therapeutics based on the license of SHUTi to Pear Therapeutics. This license is for an early version of the system and does not include the version utilized in the study described in this paper.

Ann Sollinger

  • Nothing to Disclose